Vimedimex Medi-Pharma JSC (HOSE:VMD)
Vietnam · Delayed Price · Currency is VND 14,250
-200 (-1.38%)
At close: Sep 23, 2026
Vimedimex Medi-Pharma JSC Revenue
Vimedimex Medi-Pharma JSC had revenue of 123.68B VND in the half year ending June 30, 2026, a decrease of -79.83%. This brings the company's revenue in the last twelve months to 399.90B, down -65.92% year-over-year. In the year 2025, Vimedimex Medi-Pharma JSC had annual revenue of 812.98B, down -34.95%.
Revenue (ttm)
399.90B
Revenue Growth
-65.92%
P/S Ratio
0.55
Revenue / Employee
11.43B
Employees
35
Market Cap
220.02B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 812.98B | -436.89B | -34.95% |
| Jan 1, 2025 | 1.25T | -2.29T | -64.66% |
| Dec 31, 2023 | 3.54T | -3.54T | -50.00% |
| Jan 1, 2023 | 7.07T | -5.25T | -42.58% |
| Dec 31, 2021 | 12.32T | -5.84T | -32.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Vidipha Central Pharmaceutical JSC | 979.05B |
| Ben Tre Pharmaceutical JSC | 873.41B |
| Pharmedic Pharmaceutical Medicinal JSC | 546.31B |
| Central Pharmaceutical Joint Stock Company No3 | 515.53B |
| Mediplantex National Pharmaceutical JSC | 291.40B |
| Lamdong Pharmaceutical JSC | 262.06B |
| SPM Corporation | 217.45B |
| Cai Lay Veterinary Pharmaceutical JSC | 153.97B |